|
Age, years, median (range)
|
69 (49–92)
|
|
Gender
| |
|
Male
|
55 (78.6%)
|
|
Female
|
15 (21.4)
|
|
History of prior TUR-BT
| |
|
Initial treatment
|
50 (71.4%)
|
|
Recurrence after previous TURBT
|
20 (28.6%)
|
|
ECOG Performance status
| |
|
0
|
26 (37.1%)
|
|
1
|
43 (61.5%)
|
|
2
|
1 (1.4%)
|
|
Comorbidities
| |
|
No
|
20 (28.6%)
|
|
Yes
|
50 (71.4%)
|
|
Pathology
| |
|
Transitional cell carcinoma
|
65 (92.9%)
|
|
Adenocarcinoma
|
1 (1.4%)
|
|
Other histology or missing record
|
4 (5.7%)
|
|
Grade
| |
|
High
|
55 (78.6%)
|
|
Low
|
1 (1.4%)
|
|
Missing record
|
14 (20.0%)
|
|
Clinical T stage
| |
|
T2
|
41 (58.6%)
|
|
T3
|
16 (22.9%)
|
|
T4
|
13 (18.6%)
|
|
Focality
| |
|
Multifocal
|
26 (37.2%)
|
|
Single
|
44 (62.8%)
|
|
Hydronephrosis
| |
|
No
|
39 (55.7%)
|
|
Yes
|
31 (44.3%)
|
|
Procedure before radiotherapy (RT)
| |
|
Transurethral resection (TUR)
|
64 (91.4%)
|
|
Partial cystectomy
|
4 (5.7%)
|
|
Cystoscopic biopsy only
|
2 (2.9%)
|
